LINQ PHARMA CONSULTING, INC. Trademark

Trademark Overview


On Saturday, March 16, 2024, a trademark application was filed for LINQ PHARMA CONSULTING, INC. with the United States Patent and Trademark Office. The USPTO has given the LINQ PHARMA CONSULTING, INC. trademark a serial number of 98453025. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, September 25, 2024. This trademark is owned by Linq Pharma Consulting, Inc.. The LINQ PHARMA CONSULTING, INC. trademark is filed in the Computer & Software Services & Scientific Services, Medical & Beauty Services & Agricultural Services, Personal, and Legal & Social Services categories with the following description:

Regulatory compliance consultancy in the field of pharmaceuticals; Regulatory compliance consulting in the field of pharmaceuticals

Medical and pharmaceutical consultation

Consulting services in the field of pharmaceutical research; Consulting services in the field of pharmaceutical research and development; Technical consulting in the field of pharmaceutical studies
linq pharma consulting, inc.

General Information


Serial Number98453025
Word MarkLINQ PHARMA CONSULTING, INC.
Filing DateSaturday, March 16, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, September 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of stick figure outline of a human head facing right showing a representation of the brain inside a skull, nose, and neck with the phrase 'Linq Pharma Consulting, Inc.' underneath the image. The line drawing of the human head, brain, and neck appear in teal or turquoise color and the the lettering underneath is deeper teal.
Indication of Colors claimedThe color(s) teal, deep blue-green, and turquoise is/are claimed as a feature of the mark.
Goods and ServicesRegulatory compliance consultancy in the field of pharmaceuticals; Regulatory compliance consulting in the field of pharmaceuticals
Goods and ServicesMedical and pharmaceutical consultation
Goods and ServicesConsulting services in the field of pharmaceutical research; Consulting services in the field of pharmaceutical research and development; Technical consulting in the field of pharmaceutical studies

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, March 16, 2024
Primary Code042
First Use Anywhere DateTuesday, April 7, 2015
First Use In Commerce DateTuesday, April 7, 2015

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, March 16, 2024
Primary Code044
First Use Anywhere DateTuesday, April 7, 2015
First Use In Commerce DateTuesday, April 7, 2015

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, March 16, 2024
Primary Code045
First Use Anywhere DateTuesday, April 7, 2015
First Use In Commerce DateTuesday, April 7, 2015

Trademark Owner History


Party NameLinq Pharma Consulting, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAldie, VA 20105

Trademark Events


Event DateEvent Description
Saturday, March 16, 2024NEW APPLICATION ENTERED
Sunday, August 11, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 21, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, September 25, 2024NON-FINAL ACTION E-MAILED
Wednesday, September 25, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 25, 2024ASSIGNED TO EXAMINER
Wednesday, September 25, 2024NON-FINAL ACTION WRITTEN